Pathogenesis of Marek's Disease (MD) and Possible Mechanisms of Immunity Induced by MD Vaccine

55Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Marek's disease (MD) is a lymphoproliferative disease of chicken, which is characterized by malignant T cell-lymphoma formation. This disease can be effectively prevented by vaccination with attenuated MD virus (MDV), apathogenic MDV or herpesvirus of turkey. MD vaccines are ones of a few vaccines which can prevent virus-induced tumor among mammalian and avian species. To determine the roles of T cell subsets in the protection mechanism, chickens vaccinated with an attenuated MDV (CV1988) were depleted of either CD4+ or CD8+T cells by neonatal thymectomy and injections of monoclonal antibodies against chicken CD4 or CD8 molecules and then challenged with an oncogenic MDV. These birds were effectively protected from MDV-induced tumors. However, virus titers in CD4+T cells, which are the main target cells for MDV-latent infection and subsequent transformation, were much higher in CD8-deficient vaccinated chickens than in untreated vaccinated chickens at the early stage of the latent phase. These results suggested that CD8+T cell responses induced by the MD vaccine are essential for anti-virus but not anti-tumor effects. Here, we will discuss how the attenuated vaccine prevents chickens from lymphoma-formation by an oncogenic MDV.

Cite

CITATION STYLE

APA

Morimura, T., Ohashi, K., Sugimoto, C., & Onuma, M. (1998). Pathogenesis of Marek’s Disease (MD) and Possible Mechanisms of Immunity Induced by MD Vaccine. Journal of Veterinary Medical Science. Maruzen Co. Ltd. https://doi.org/10.1292/jvms.60.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free